ContraFect Corp (CFRX)

3.83 -0.04  -1.03% NASDAQ Oct 22, 16:00 3.80 -0.03  -0.78% After-Hours: 20:00 USD
View Full Chart
Price Chart
View All CFRX News

News

View All Events

Events

Date Type Description
11/12/2021 Earnings Results Q3 2021 Earnings Results
08/13/2021 Earnings Results Q2 2021 Earnings Results
05/18/2021 09:00 EST AGM 2020 Annual General Meeting
05/14/2021 Earnings Results Q1 2021 Earnings Results
03/30/2021 Earnings Results Q4 2020 Earnings Results
11/13/2020 Earnings Results Q3 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: ContraFect Corp is a late clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections. Its lysin exebacase has a targeted spectrum of activity, meaning that it kills specific species of Staphylococci or closely related bacteria. Its IND candidate, CF-370, targets resistant gram-negative bacteria including Pseudomonas aeruginosa (P. aeruginosa). Its advanced clinical candidate, exebacase, is an investigational novel lysin that targets Staphylococcus aureus (Staph aureus), including methicillin-resistant (MRSA) strains, which causes serious infections such as bacteremia, pneumonia and osteomyelitis.
  • URL: https://www.contrafect.com
  • Investor Relations URL: http://investors.contrafect.com/phoenix.zhtml?c=253647&p=irol-IRHome
  • HQ State/Province: New York
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Nov. 12, 2021
  • Last Earnings Release: Aug. 13, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
JMIGX Jacob Discovery Fd Instl 1.54%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.